Mok CK - Search Results

1

Antiviral Activity of Catechin against Dengue Virus Infection.

Yi B, Chew BXZ, Chen H, Lee RCH, Fong YD, Chin WX, Mok CK, Chu JJH. Yi B, et al. Among authors: mok ck. Viruses. 2023 Jun 15;15(6):1377. doi: 10.3390/v15061377. Viruses. 2023. PMID: 37376676 Free PMC article.

2

Antiviral Natural Products for Arbovirus Infections.

Goh VSL, Mok CK, Chu JJH. Goh VSL, et al. Among authors: mok ck. Molecules. 2020 Jun 17;25(12):2796. doi: 10.3390/molecules25122796. Molecules. 2020. PMID: 32560438 Free PMC article. Review.

3

Current Perspective of Antiviral Strategies against COVID-19.

Ahidjo BA, Loe MWC, Ng YL, Mok CK, Chu JJH. Ahidjo BA, et al. Among authors: mok ck. ACS Infect Dis. 2020 Jul 10;6(7):1624-1634. doi: 10.1021/acsinfecdis.0c00236. Epub 2020 Jun 16. ACS Infect Dis. 2020. PMID: 32485102 Review.

4

Adenovirus vectored IFN-α protects mice from lethal challenge of Chikungunya virus infection.

Chen H, Min N, Ma L, Mok CK, Chu JJH. Chen H, et al. Among authors: mok ck. PLoS Negl Trop Dis. 2020 Dec 3;14(12):e0008910. doi: 10.1371/journal.pntd.0008910. eCollection 2020 Dec. PLoS Negl Trop Dis. 2020. PMID: 33270642 Free PMC article.

5

Cytopathic Effect (CPE )-Based Drug Screening Assay for SARS-CoV-2.

Ng YL, Mok CK, Chu JJH. Ng YL, et al. Among authors: mok ck. Methods Mol Biol. 2022;2452:379-391. doi: 10.1007/978-1-0716-2111-0_22. Methods Mol Biol. 2022. PMID: 35554918

6

Contribution of Fc-dependent cell-mediated activity of a vestigial esterase-targeting antibody against H5N6 virus infection.

Zheng Z, Teo SHC, Arularasu SC, Liu Z, Mohd-Ismail NK, Mok CK, Ong CB, Chu JJ, Tan YJ. Zheng Z, et al. Among authors: mok ck. Emerg Microbes Infect. 2020 Jan 6;9(1):95-110. doi: 10.1080/22221751.2019.1708215. eCollection 2020. Emerg Microbes Infect. 2020. PMID: 31906790 Free PMC article.

7

Evaluation of In Vitro and In Vivo Antiviral Activities of Vitamin D for SARS-CoV-2 and Variants.

Mok CK, Ng YL, Ahidjo BA, Aw ZQ, Chen H, Wong YH, Lee RCH, Loe MWC, Liu J, Tan KS, Kaur P, Wang Y, Hao E, Hou X, Tan YW, Deng J, Chu JJH. Mok CK, et al. Pharmaceutics. 2023 Mar 12;15(3):925. doi: 10.3390/pharmaceutics15030925. Pharmaceutics. 2023. PMID: 36986786 Free PMC article.

8

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.

Shan S, Mok CK, Zhang S, Lan J, Li J, Yang Z, Wang R, Cheng L, Fang M, Aw ZQ, Yu J, Zhang Q, Shi X, Zhang T, Zhang Z, Wang J, Wang X, Chu JJH, Zhang L. Shan S, et al. Among authors: mok ck. Front Immunol. 2021 Dec 13;12:766821. doi: 10.3389/fimmu.2021.766821. eCollection 2021. Front Immunol. 2021. PMID: 34966387 Free PMC article.

9

Airborne SARS-CoV-2 surveillance in hospital environment using high-flowrate air samplers and its comparison to surface sampling.

Ang AX, Luhung I, Ahidjo BA, Drautz-Moses DI, Tambyah PA, Mok CK, Lau KJ, Tham SM, Chu JJH, Allen DM, Schuster SC. Ang AX, et al. Among authors: mok ck. Indoor Air. 2022 Jan;32(1):e12930. doi: 10.1111/ina.12930. Epub 2021 Sep 14. Indoor Air. 2022. PMID: 34519380 Free PMC article.

10

A monoclonal antibody binds to threonine 49 in the non-structural 1 protein of influenza A virus and interferes with its ability to modulate viral replication.

Barnwal B, Mok CK, Wu J, Diwakar MK, Gupta G, Zeng Q, Chow VT, Song J, Yuan YA, Tan YJ. Barnwal B, et al. Among authors: mok ck. Antiviral Res. 2015 Apr;116:55-61. doi: 10.1016/j.antiviral.2015.01.015. Epub 2015 Feb 7. Antiviral Res. 2015. PMID: 25666762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

240 results

Search Page